source
- Michael J. Fox Foundation backs Ariadne Bio's non-hallucinogenic psychedelic for Parkinson'sAriadne Bio, a new biotech focused on Parkinson's disease, has received backing from the Michael J. Fox Foundation. The partnership centers on a non‑hallucinogenic psychedelic candidate that the fo…
- Roche partners with Dualitas Therapeutics in up to $1 billion deal to screen bispecific antibodies for immune diseasesRoche has committed $36.5 million up front to biotechnology startup Dualitas Therapeutics under a research partnership that could total up to $1 billion in milestone payments and royalties. The agr…